Y. Vidal

Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study

J. Cueva, E. Gallardo, Jorge A. Garcia, 2012, Investigational New Drugs.

The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens

Á. Carracedo, R. López, F. Barros, 2012, Cancer Chemotherapy and Pharmacology.

Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer.

Á. Carracedo, E. Gallardo, R. López, 2011, Pharmacogenomics.

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients

J. Albanell, B. Bellosillo, C. Montagut, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Concordance between blood- and tumor-based detection of RAS mutations to guide therapy in metastatic colorectal cancer.

A. Montes, Y. Vidal, M. Rúa, 2020 .

Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer

R. López-López, A. Férnández-Montes, L. Muinelo-Romay, 2023, Cancers.

The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens.

Á. Carracedo, R. López, F. Barros, 2011, Cancer chemotherapy and pharmacology.